ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Internal Medicine

Top Internal Medicine Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WENDY OATIS MD

Internal Medicine

224

$22.1K

54
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $56

DAVID KOETS MD

Internal Medicine

352

$14.7K

23
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $56

KATRINA WAGONER-HURSH MD

Internal Medicine

353

$15.9K

87
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $56

EDWARD SMITH MD

Internal Medicine

439

$60.4K

86
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 24%

$138
Average prescription price

Avg: $56

ROCIO PEREIRA MD

Internal Medicine

464

$31.6K

84
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $56

DANIEL MATLOCK MD

Internal Medicine

464

$19.5K

53
27 are 65+

21%
patients receiving schedule two controlled substances

Avg: 8%

26%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $56

KRISTINE KUHN MD

Internal Medicine

481

$206K

37
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$429
Average prescription price

Avg: $56

STAR FOWLER D.O.

Internal Medicine

517

$24.2K

61
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $56

AMRUT AMBARDEKAR MD

Internal Medicine

565

$23.2K

51
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $56

DIANE MELANCON MD

Internal Medicine

602

$72.2K

97
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 24%

$120
Average prescription price

Avg: $56

PAUL HASSETT

Internal Medicine

612

$42.1K

87
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $56

OSCAR DOMINGUEZ MD

Internal Medicine

618

$37.5K

91
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $56

KIM TYLER

Internal Medicine

633

$93.4K

108
78 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $56

MICHAEL BORKOWSKI PA

Internal Medicine

633

$22.7K

318
274 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $56

AARON CALDERON MD

Internal Medicine

640

$42.3K

79
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $56

GRACE ALESSI MD

Internal Medicine

651

$35.7K

85
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $56

DAVID HAGER MD

Internal Medicine

668

$40.7K

80
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $56

BARRY ESKINS MD

Internal Medicine

711

$33.1K

143
134 are 65+

50%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $56

SCOTT KONO DO

Internal Medicine

714

$195K

107
76 are 65+

48%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$274
Average prescription price

Avg: $56

ROBIN SADKER MD

Internal Medicine

715

$35.6K

79
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $56

CHRISTOPHER BLICHARSKI M.D.

Internal Medicine

737

$132K

85
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 24%

$179
Average prescription price

Avg: $56

ANNEMARIE WHIDDON M.D.

Internal Medicine

771

$83.8K

88
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$109
Average prescription price

Avg: $56

LORANNE GIBANS MD

Internal Medicine

783

$55.4K

101
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $56

RICHARD DUCHARME M.D.

Internal Medicine

789

$50.9K

127
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $56

JEFFREY PICKARD M.D.

Internal Medicine

802

$40.9K

151
68 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank